N. Furuya - Department of Internal Medicine, St.Marianna University School of Medicine

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 42 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

MO37-3 Construction of Data for Implementation of Comprehensive Cancer Genome Profiling Using Genome-Guided System

Y. Sunakawa, H. Arai, H. Yamamoto, A. Motoyoshi, O. Migita, T. Ohara,N. Furuya, K. Imoto, S. Hettich, I. Avi Cemel, L. Kyjacova, M. Rauschendorf, Y. Yamano

ANNALS OF ONCOLOGY (2024): S1346-S1346

Cited0Views0Bibtex

The Impact of Antibiotic Use on ICI Plus Chemotherapy Versus Chemotherapy in NSCLC Patients with PD-L1 Expression of 1% to 49%

Y. Toyota, T. Hata,T. Yamada,Y. Goto,T. Kijima, S. Watanabe,N. Furuya,T. Oba,T. Ikoma, A. Nakao,K. Tanimura,H. Taniguchi,A. Yoshimura, T. Fukui, D. Murata,K. Kaira,S. Shiotsu, M. Hibino,A. Okada,K. Takayama

ANNALS OF ONCOLOGY (2024)

Cited0Views0Bibtex

EP.13E.02 Multi-Omics Analysis of Patients with Extended-Disease Small Cell Lung Cancer Who Received Chemoimmunotherapy: APOLLO-Bio Study

H. Akamatsu,D. Fujimoto,M. Nakatochi,M. Tamiya,T. Kijima,Y. Sato, H. Matsumoto,A. Hata,S. Hara,Y. Taniguchi,T. Yokoyama,J. Uchida,S. Miura,N. Furuya,J. Sugisaka,E. Miyauchi,S. Sakata, H. Tanaka,N. Yamamoto,Y. Koh

Journal of Thoracic Oncologyno. 10 (2024): S681

Cited0Views0Bibtex

709P the Impact of Antibiotic Use on ICI Plus Chemotherapy Versus Chemotherapy in NSCLC Patients with PD-L1 Expression of 1% to 49%

Annals of Oncology (2024): S1669

Cited0Views0Bibtex

Multi-Omics Analysis of Patients with ExtendedDisease Small Cell Lung Cancer Who Received Chemoimmunotherapy: APOLLO-Bio Study

H. Akamatsu,D. Fujimoto,M. Nakatochi,M. Tamiya,T. Kijima, Y. Sato, H. Matsumoto,A. Hata,S. Hara,Y. Taniguchi,T. Yokoyama,J. Uchida,S. Miura,N. Furuya,J. Sugisaka,E. Miyauchi,S. Sakata, H. Tanaka,N. Yamamoto,Y. Koh

JOURNAL OF THORACIC ONCOLOGYno. 10 (2024): S681-S681

Cited0Views0Bibtex

A Phase II Study on Aggressive Local Consolidative Therapy in Combination with Chemotherapy for Oligometastic NSCLC: TORG1529

T. Tokito,K. Yamada,H. Ishii,Y. Takiguchi,G. Saito,K. Minato,H. Imai,H. Tanaka,S. Miura,K. Watanabe,Y. Koreeda,A. Ono,N. Furuya,T. Misumi,K. Hayakawa,E. Ogo,H. Okamoto

JOURNAL OF THORACIC ONCOLOGYno. 11 (2023): S596-S596

Cited0Views0Bibtex

EP09.02-03 A Phase II Study on Aggressive Local Consolidative Therapy in Combination with Chemotherapy for Oligometastic NSCLC: TORG1529

T. Tokito,K. Yamada,H. Ishii,Y. Takiguchi,G. Saito,K. Minato,H. Imai,H. Tanaka,S. Miura, K. Watanabe,Y. Koreeda,A. Ono,N. Furuya,T. Misumi,K. Hayakawa,E. Ogo,H. Okamoto

Journal of Thoracic Oncologyno. 11 (2023): S596

Cited0Views0Bibtex

P2.14-03 Outcomes of Chemoimmunotherapy in Patients with ES-SCLC According to Liver Metastasis: A Multicenter Prospective Cohort Study

JOURNAL OF THORACIC ONCOLOGYno. 11 (2023): S371-S372

Cited0Views0Bibtex

P2.23-02 Prospective Observational Study of Cachexia and Its Effect on Systemic Therapy in Patients with Previously-Untreated Advanced NSCLC (NEJ050A)

N. Furuya,K. Miura,T. Shukuya,R. Morita,A. Kisohara,A. Mouri,S. Watanabe,H. Tanaka, A. Hirata,T. Hakozaki,K. Hamai,N. Matsumoto, K. Watanabe,H. Ashinuma,E. Miyauchi, K. Sugano,S. Hosokawa,H. Asahina,R. Koyama, T. Tamura,N. Kanaji, T. Nakagawa, M. Kamimura,K. Isobe, T. Tsuda,S. Morita-Tanaka,D. Arai,H. Nagashima,D. Jingu,T. Ibe,K. Usui, M. Matsumoto,Y. Masui,M. Miyazaki,S. Morita,K. Kobayashi,K. Takahashi

Journal of Thoracic Oncologyno. 11 (2023)

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn